Wednesday, April 20, 2022 Daily Archives

Minimize Risk With Rapid At-Line Concentration Measurement in Downstream Bioprocessing Applications

by

This webcast features: Paul Mania, Bioanalytics Applications Specialist, Repligen. Traditional UV/Vis spectroscopy uses fixed pathlengths to measure different analytes, such as nucleic acids, proteins, and cells from biological samples. These samples are often limited in volume or highly concentrated, which presents various challenges. The CTech™ SoloVPE® System uses a patented variable pathlength technology (VPT) to accurately measure the targeted concentration of various analytes. The system measures concentrations without being dependent on sample volume or sample concentration, removing any dilution requirements,…

April 20, 2022

Gilead’s Kite receives US FDA ok for Maryland CAR-T plant

by

The 20-acre site in Frederick, Maryland will produce CAR-T therapy Yescarta and increase its network capacity by 50%, says Kite. In 2018, Gilead Sciences, fresh from its $11.9 billion acquisition of Kite Pharma, announced plans to expand its manufacturing network with a 275,000 square foot facility in Frederick County, Marland to produce chimeric antigen receptor (CAR) T-cell therapies. Now, the firm has received approval from the US Food and Drug Administration (FDA) to manufacture CAR-T cell therapy Yescarta (axicabtagene ciloleucel), which was…

April 20, 2022

Asahi Kasei enters CDMO biz with Bionova buy

by

Through the acquisition of Bionova Scientific, the US arm of Asahi Kasei Medical will add a full-service biologics CDMO to its arsenal. US-based Bionova, which fully transitioned into a contract development and manufacturing organization (CDMO) in November 2021 with the opening of its $25 million Fremont, California facility says the acquisition adds a “strategic complementary addition†to Asahi Kasei’s bioprocess consumables, equipment, and biosafety testing services business. “We are extremely excited to become a part of Asahi Kasei. This represents…

April 20, 2022